This invention is directed to a compound of formula (I):
wherein R
1
, R
2
, R
3
and L
1
are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD).
This invention is directed to a compound of formula (I):
wherein R1, R2, R3 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD).
[EN] PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS<br/>[FR] COMPOSÉS D'AMIDE DE PYRIMIDINE EN TANT QU'INHIBITEURS DE LA PGDS
申请人:AVENTIS PHARMA INC
公开号:WO2007041634A1
公开(公告)日:2007-04-12
[EN] This invention is directed to a compound of formula (I): wherein R1, R2, R3 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD). [FR] L'invention concerne un composé selon la formule (I) dans laquelle R1, R2, R3 et L1 sont tels que définis ici, une composition pharmaceutique comprenant ledit composé et l'utilisation de ce composé pour traiter des troubles allergiques et/ou inflammatoires, particulièrement des troubles tels qu'une rhinite allergique, l'asthme et/ou une bronchopneumopathie chronique obstructive (BPCO).